Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the stock.

Several other research analysts have also issued reports on EKSO. Lake Street Capital lowered their price target on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. HC Wainwright lowered their target price on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th.

Ekso Bionics Stock Performance

Shares of Ekso Bionics stock opened at $0.73 on Monday. The stock has a market cap of $16.06 million, a price-to-earnings ratio of -1.12 and a beta of 1.47. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. Ekso Bionics has a twelve month low of $0.50 and a twelve month high of $3.03. The company’s fifty day moving average is $0.72 and its 200 day moving average is $0.97.

Ekso Bionics (NASDAQ:EKSO) last released its quarterly earnings results on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. The company had revenue of $4.13 million during the quarter, compared to the consensus estimate of $6.00 million. During the same quarter last year, the firm posted ($0.24) EPS. Sell-side analysts forecast that Ekso Bionics will post -0.48 EPS for the current year.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.